12:00 AM
 | 
Feb 03, 2003
 |  BioCentury  |  Tools & Techniques

Molecular Staging: Catching sepsis

Diagnosing sepsis is not easy. As a result, doctors often lose precious time before prescribing Xigris drotrecogin alfa from Eli Lilly and Co., which is marketed to treat the condition. Last week, LLY hired protein chip company Molecular Staging Inc. to identify serum biomarkers that could be used to develop a diagnostic test for sepsis.

Xigris recombinant human activated protein C was approved in the U.S. in late 2001 and in Europe last fall. "It's the first time that physicians have had a drug available to them for sepsis, but there still isn't a test that will allow you to say, 'OK, this is...

Read the full 519 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >